Page 100 - ITPS-7-4

INNOSC Theranostics and
Pharmacological Sciences LMWH for VTE prophylaxis in acute stroke patients

transformation of brain infarct: Predictability in the first 5 2017;9(12):e1982.
hours from stroke onset and influence on clinical outcome.
Neurology. 1996;46(2):341-345. doi: 10.7759/cureus.1982
20. CLOTS Trials Collaboration, Dennis M, Sandercock P, et al.
doi: 10.1212/WNL.46.2.341
The effect of graduated compression stockings on long-term
10. Hong JM, Kim DS, Kim M. Hemorrhagic transformation outcomes after stroke: The CLOTS trials 1 and 2. Stroke.
after ischemic stroke: Mechanisms and management. Front 2013;44(4):1075-1079.
Neurol. 2021;12:703258.
doi: 10.1161/STROKEAHA.111.680298
doi: 10.3389/fneur.2021.703258
21. CLOTS (Clots in Legs Or sTockings after Stroke) Trials
11. D’Amelio M, Terruso V, Famoso G, et al. Early and late Collaboration. Effect of intermittent pneumatic compression
mortality of spontaneous hemorrhagic transformation on disability, living circumstances, quality of life, and
of ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(4): hospital costs after stroke: Secondary analyses from CLOTS
649-654. 3, a randomised trial. Lancet Neurol. 2014;13(12):1186-1192.
doi: 10.1016/j.jstrokecerebrovasdis.2013.06.005 22. CLOTS Trials Collaboration. Effectiveness of thigh-length
12. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic graduated compression stockings to reduce the risk of deep
transformation within 36 hours of a cerebral infarct: vein thrombosis after stroke (CLOTS trial 1): A multicentre,
Relationships with early clinical deterioration and 3-month randomised controlled trial. Lancet. 2009;373(9679):
outcome in the European Cooperative Acute Stroke Study I 1958-1965.
(ECASS I) cohort. Stroke. 1999;30(11):2280-2284. doi: 10.1016/S0140-6736(09)60941-7
doi: 10.1161/01.STR.30.11.2280 23. Whiteley WN, Adams HP, Bath PM, et al. Targeted use of
13. Arba F, Rinaldi C, Caimano D, Vit F, Busto G, Fainardi E. heparin, heparinoids, or low-molecular-weight heparin to
Blood-brain barrier disruption and hemorrhagic improve outcome after acute ischaemic stroke: An individual
transformation in acute ischemic stroke: Systematic review patient data meta-analysis of randomised controlled trials.
and meta-analysis. Front Neurol. 2021;11:594613. Lancet Neurol. 2013;12(6):539-545.
doi: 10.3389/fneur.2020.594613 doi: 10.1016/S1474-4422(13)70079-6
14. Kadry H, Noorani B, Cucullo L. A blood-brain barrier 24. Geeganage CM, Sprigg N, Bath MW, Bath PM. Balance
overview on structure, function, impairment, and of symptomatic pulmonary embolism and symptomatic
biomarkers of integrity. Fluids Barriers CNS. 2020;17:1-24. intracerebral hemorrhage with low-dose anticoagulation
doi: 10.1186/s12987-020-00230-3 in recent ischemic stroke: A systematic review and meta-
analysis of randomized controlled trials. J Stroke Cerebrovasc
15. Kaplan L, Chow BW, Gu C. Neuronal regulation of the Dis. 2013;22(7):1018-1027.
blood-brain barrier and neurovascular coupling. Nat Rev
Neurosci. 2020;21(8):416-432. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.005
doi: 10.1038/s41583-020-0322-2 25. Sandercock PA, Counsell C, Kane EJ. Anticoagulants
for acute ischaemic stroke. Cochrane Database Syst Rev.
16. Khatri R, McKinney AM, Swenson B, Janardhan V. 2015;2015(3):CD000024.
Blood-brain barrier, reperfusion injury, and hemorrhagic
transformation in acute ischemic stroke. Neurology. doi: 10.1002/14651858.CD000024.pub4
2012;79:S52-S57. 26. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight
doi: 10.1212/WNL.0b013e3182697e70 heparins and heparinoids in acute ischemic stroke:
A meta-analysis of randomized controlled trials. Stroke.
17. Kalinin MN, Khasanova DR, Ibatullin MM. The hemorrhagic 2000;31(7):1770-1778.
transformation index score: A prediction tool in middle
cerebral artery ischemic stroke. BMC Neurol. 2017;17:1-6. doi: 10.1161/01.STR.31.7.1770
doi: 10.1186/s12883-017-0958-3 27. Bath P, Leonardi-Bee J, Bath F. Low molecular weight heparin
versus aspirin for acute ischemic stroke: A systematic review.
18. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines J Stroke Cerebrovasc Dis. 2002;11(2):55-62.
for the management of atrial fibrillation developed in
collaboration with EACTS. Polish Heart J (Kardiologia doi: 10.1053/jscd.2002.126694
Polska). 2016;74(12):1359-1469.
28. Ikoma H. Development of argatroban as an anticoagulant
doi: 10.5603/KP.2016.0172 and antithrombin agent in Japan. Pathophysiol Haemost
Thromb. 2002;32(Suppl. 3):23-28.
19. Khan MT, Ikram A, Saeed O, et al. Deep vein thrombosis
in acute stroke - A systemic review of the literature. Cureus. doi: 10.1159/000069105

Volume 7 Issue 4 (2024) 7 doi: 10.36922/itps.3250